Study details
Enrolling now
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
Albany Medical College
NCT IDNCT06517901ClinicalTrials.gov data as of Apr 2026
Target enrollment
1,306
Study length
about 2.2 years
Ages
18+
Sex
Male only
Locations
3 sites in MA, NY, PA
About this study
Researchers are testing whether cognitive fusion or software fusion ultrasound-guided biopsies are better at detecting prostate cancer in men with suspicious lesions on MRI. The trial will compare the detection rates of clinically significant prostate cancer following either the cognitive or the fusion targeted prostate biopsy.
Based on ClinicalTrials.gov records.
What participants do
- 1.Undergo Cognitive fusion prostate biopsy
- 2.Undergo Software fusion prostate biopsy
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Procedures
biopsy
Body systems
Oncology